一图看懂精锋医疗(2675.HK)IPO

Company Overview - Jingfeng Medical, established in 2017, focuses on the research and development of surgical robots, aiming to design, develop, and manufacture surgical robots. The company currently has three products at different stages of development, including multi-port laparoscopic surgical robots, single-port laparoscopic surgical robots, and natural orifice surgical robots [8][21]. Product Pipeline - The product lineup includes two core products: Jingfeng's multi-port laparoscopic surgical robot and single-port laparoscopic surgical robot. The company has developed a comprehensive technology platform with seven core proprietary technology modules [8][24]. - The MP1000 is the first laparoscopic surgical robot approved for multiple surgical specialties, while the SP1000 is the first single-port laparoscopic surgical robot approved by the National Medical Products Administration (NMPA) for gynecological surgeries [21][22]. Market Size - The global surgical robot market is projected to grow significantly, with a compound annual growth rate (CAGR) of 18.9% from 2019 to 2024, 12.0% from 2024 to 2030, and 22.4% from 2030 to 2033. The market size is expected to reach approximately $84.19 billion by 2033 [15][19]. Industry Position - Jingfeng Medical has achieved significant milestones, including obtaining NMPA approval for the MP1000 in December 2022 and expanding its application range to gynecology, general surgery, and thoracic surgery by August 2023. The company has also received approval for the upgraded MP1000 Plus model in October 2023 [21][22]. - As of the latest available data, over 12,000 robotic-assisted clinical surgeries in China have been performed using the company's multi-port laparoscopic surgical robot, and over 2,000 surgeries using the single-port laparoscopic surgical robot [23][24]. Financial Data - The total revenue for the company is projected to be 1.60 billion RMB in 2023, with forecasts of 1.49 billion RMB in 2024 and 0.48 billion RMB by June 30, 2025. The financial figures indicate a growing trend in revenue generation [37][38].